Rank | Gene Set | Z-score |
---|---|---|
1 | central nervous system myelination (GO:0022010) | 9.83995480 |
2 | axon ensheathment in central nervous system (GO:0032291) | 9.83995480 |
3 | fatty acid elongation (GO:0030497) | 7.60302699 |
4 | surfactant homeostasis (GO:0043129) | 6.09431003 |
5 | myelin maintenance (GO:0043217) | 5.86653956 |
6 | ensheathment of neurons (GO:0007272) | 5.56801037 |
7 | axon ensheathment (GO:0008366) | 5.56801037 |
8 | regulation of memory T cell differentiation (GO:0043380) | 5.54314313 |
9 | myelination (GO:0042552) | 5.51841386 |
10 | long-chain fatty acid biosynthetic process (GO:0042759) | 5.07495837 |
11 | adhesion of symbiont to host cell (GO:0044650) | 4.93711689 |
12 | virion attachment to host cell (GO:0019062) | 4.93711689 |
13 | chemical homeostasis within a tissue (GO:0048875) | 4.76732947 |
14 | positive regulation of vasculogenesis (GO:2001214) | 4.31790523 |
15 | photoreceptor cell differentiation (GO:0046530) | 4.29802948 |
16 | eye photoreceptor cell differentiation (GO:0001754) | 4.29802948 |
17 | negative regulation of multicellular organism growth (GO:0040015) | 4.23745683 |
18 | apical protein localization (GO:0045176) | 4.22313709 |
19 | asymmetric protein localization (GO:0008105) | 4.19033100 |
20 | amyloid precursor protein metabolic process (GO:0042982) | 4.16930468 |
21 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 4.08563433 |
22 | indole-containing compound catabolic process (GO:0042436) | 4.08092138 |
23 | indolalkylamine catabolic process (GO:0046218) | 4.08092138 |
24 | tryptophan catabolic process (GO:0006569) | 4.08092138 |
25 | oligodendrocyte differentiation (GO:0048709) | 4.07369857 |
26 | negative regulation of neurotransmitter secretion (GO:0046929) | 4.06893657 |
27 | cholesterol biosynthetic process (GO:0006695) | 4.06844456 |
28 | cellular response to cadmium ion (GO:0071276) | 3.87095927 |
29 | adhesion of symbiont to host (GO:0044406) | 3.79593833 |
30 | molting cycle (GO:0042303) | 3.77733880 |
31 | hair cycle (GO:0042633) | 3.77733880 |
32 | regulation of MHC class I biosynthetic process (GO:0045343) | 3.77602934 |
33 | kynurenine metabolic process (GO:0070189) | 3.75371146 |
34 | negative regulation of protein localization to cell surface (GO:2000009) | 3.74505295 |
35 | regulation of vasculogenesis (GO:2001212) | 3.69800137 |
36 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.69193405 |
37 | response to lipoprotein particle (GO:0055094) | 3.68971482 |
38 | cellular response to zinc ion (GO:0071294) | 3.67006478 |
39 | sterol catabolic process (GO:0016127) | 3.64231012 |
40 | cholesterol catabolic process (GO:0006707) | 3.64231012 |
41 | negative regulation of neurotransmitter transport (GO:0051589) | 3.60790960 |
42 | regulation of branching involved in prostate gland morphogenesis (GO:0060687) | 3.57074178 |
43 | sterol biosynthetic process (GO:0016126) | 3.54436566 |
44 | negative regulation of type 2 immune response (GO:0002829) | 3.54300661 |
45 | regulation of sequestering of triglyceride (GO:0010889) | 3.53207134 |
46 | regulation of metalloenzyme activity (GO:0048552) | 3.51660318 |
47 | lateral sprouting from an epithelium (GO:0060601) | 3.51614292 |
48 | amyloid precursor protein catabolic process (GO:0042987) | 3.51284099 |
49 | positive regulation of lipid storage (GO:0010884) | 3.50912517 |
50 | limb bud formation (GO:0060174) | 3.47794152 |
51 | positive regulation of heat generation (GO:0031652) | 3.46427720 |
52 | lung lobe morphogenesis (GO:0060463) | 3.45346194 |
53 | protein localization to endosome (GO:0036010) | 3.43955671 |
54 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.43724664 |
55 | tryptophan metabolic process (GO:0006568) | 3.39419828 |
56 | regulation of cholesterol storage (GO:0010885) | 3.37132717 |
57 | regulation of establishment of cell polarity (GO:2000114) | 3.33359675 |
58 | iron ion import (GO:0097286) | 3.31934860 |
59 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 3.27224436 |
60 | pattern specification involved in kidney development (GO:0061004) | 3.25631362 |
61 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 3.22203982 |
62 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.20730091 |
63 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.20156719 |
64 | creatine metabolic process (GO:0006600) | 3.19878699 |
65 | negative regulation of endothelial cell apoptotic process (GO:2000352) | 3.18972092 |
66 | bile acid biosynthetic process (GO:0006699) | 3.12987848 |
67 | fatty-acyl-CoA metabolic process (GO:0035337) | 3.12709466 |
68 | regulation of somitogenesis (GO:0014807) | 3.12641847 |
69 | cytoplasmic mRNA processing body assembly (GO:0033962) | 3.11264035 |
70 | mesodermal cell differentiation (GO:0048333) | 3.09661545 |
71 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis (GO:006052 | 3.08758345 |
72 | negative regulation of complement activation (GO:0045916) | 3.07547787 |
73 | response to redox state (GO:0051775) | 3.05277151 |
74 | regulation of lipoprotein metabolic process (GO:0050746) | 3.04608427 |
75 | regulation of collateral sprouting (GO:0048670) | 3.04570982 |
76 | glycerophospholipid catabolic process (GO:0046475) | 3.03850439 |
77 | regulation of triglyceride catabolic process (GO:0010896) | 3.00856325 |
78 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.99061449 |
79 | regulation of triglyceride biosynthetic process (GO:0010866) | 2.98772559 |
80 | regulation of interleukin-13 production (GO:0032656) | 2.98073778 |
81 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 2.96645232 |
82 | very long-chain fatty acid metabolic process (GO:0000038) | 2.95516962 |
83 | import into cell (GO:0098657) | 2.95055951 |
84 | regulation of heat generation (GO:0031650) | 2.93527950 |
85 | negative regulation of mast cell activation (GO:0033004) | 2.92574729 |
86 | response to methylmercury (GO:0051597) | 2.92275259 |
87 | positive regulation of pseudopodium assembly (GO:0031274) | 2.87991988 |
88 | protein palmitoylation (GO:0018345) | 2.83359534 |
89 | keratan sulfate catabolic process (GO:0042340) | 2.82354565 |
90 | isoprenoid biosynthetic process (GO:0008299) | 2.81844530 |
91 | membrane tubulation (GO:0097320) | 2.81370830 |
92 | cellular biogenic amine catabolic process (GO:0042402) | 2.79248067 |
93 | amine catabolic process (GO:0009310) | 2.79248067 |
94 | branch elongation of an epithelium (GO:0060602) | 2.79117749 |
95 | negative regulation of protein activation cascade (GO:2000258) | 2.76482257 |
96 | magnesium ion transport (GO:0015693) | 2.75936057 |
97 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.75514165 |
98 | L-serine transport (GO:0015825) | 2.75474655 |
99 | membrane protein ectodomain proteolysis (GO:0006509) | 2.75421681 |
100 | indolalkylamine metabolic process (GO:0006586) | 2.74457055 |
101 | GPI anchor biosynthetic process (GO:0006506) | 2.73671691 |
102 | membrane raft organization (GO:0031579) | 2.73520707 |
103 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.71803467 |
104 | aromatic amino acid family catabolic process (GO:0009074) | 2.71238610 |
105 | L-amino acid import (GO:0043092) | 2.71053008 |
106 | regulation of lipid storage (GO:0010883) | 2.70974028 |
107 | sphingosine metabolic process (GO:0006670) | 2.70919887 |
108 | oligosaccharide catabolic process (GO:0009313) | 2.68121091 |
109 | organ growth (GO:0035265) | 2.67758595 |
110 | negative regulation of receptor-mediated endocytosis (GO:0048261) | 2.66957897 |
111 | peripheral nervous system axon ensheathment (GO:0032292) | 2.66933839 |
112 | myelination in peripheral nervous system (GO:0022011) | 2.66933839 |
113 | lipid storage (GO:0019915) | 2.66782042 |
114 | acyl-CoA biosynthetic process (GO:0071616) | 2.66671750 |
115 | thioester biosynthetic process (GO:0035384) | 2.66671750 |
116 | sodium-independent organic anion transport (GO:0043252) | 2.65564296 |
117 | low-density lipoprotein particle clearance (GO:0034383) | 2.64772994 |
118 | positive regulation of actin filament depolymerization (GO:0030836) | 2.64142990 |
119 | astrocyte development (GO:0014002) | 2.62585007 |
120 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.62293135 |
121 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.62086659 |
122 | enteric nervous system development (GO:0048484) | 2.61083288 |
123 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.60242019 |
124 | negative regulation of lipase activity (GO:0060192) | 2.58775676 |
125 | GPI anchor metabolic process (GO:0006505) | 2.58685092 |
126 | negative regulation of JUN kinase activity (GO:0043508) | 2.58580685 |
127 | positive regulation of protein kinase C signaling (GO:0090037) | 2.58350960 |
128 | regulation of pseudopodium assembly (GO:0031272) | 2.57615691 |
129 | positive regulation of gliogenesis (GO:0014015) | 2.55414797 |
130 | negative regulation of macrophage differentiation (GO:0045650) | 2.55141186 |
131 | tight junction assembly (GO:0070830) | 2.54520434 |
132 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.53643040 |
133 | prostate gland growth (GO:0060736) | 2.52311358 |
134 | negative regulation of protein autophosphorylation (GO:0031953) | 2.51403737 |
135 | regulation of osteoblast proliferation (GO:0033688) | 2.51272816 |
136 | sex differentiation (GO:0007548) | 2.51213139 |
137 | phosphatidylserine metabolic process (GO:0006658) | 2.50247211 |
138 | nerve growth factor signaling pathway (GO:0038180) | 2.49830257 |
139 | nucleotide transmembrane transport (GO:1901679) | 2.48696214 |
140 | Leydig cell differentiation (GO:0033327) | 2.48377399 |
141 | cellular response to ATP (GO:0071318) | 2.48312912 |
142 | regulation of phospholipid biosynthetic process (GO:0071071) | 2.47244185 |
143 | regulation of mononuclear cell migration (GO:0071675) | 2.46961878 |
144 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.45821498 |
145 | mesenchymal cell proliferation (GO:0010463) | 2.45099991 |
146 | keratinization (GO:0031424) | 2.44220331 |
147 | positive regulation of glial cell differentiation (GO:0045687) | 2.43773342 |
148 | neuron remodeling (GO:0016322) | 2.43157456 |
149 | phagocytosis, recognition (GO:0006910) | 2.43029407 |
150 | androgen biosynthetic process (GO:0006702) | 2.42910324 |
151 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 2.42627088 |
152 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 2.42559887 |
153 | establishment of mitochondrion localization (GO:0051654) | 2.41863002 |
154 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.41500837 |
155 | regulation of endothelial cell apoptotic process (GO:2000351) | 2.41155399 |
156 | diol metabolic process (GO:0034311) | 2.40604348 |
157 | negative regulation of lipid storage (GO:0010888) | 2.38937509 |
158 | lipid particle organization (GO:0034389) | 2.38900798 |
159 | bile acid metabolic process (GO:0008206) | 2.38266575 |
160 | serine transport (GO:0032329) | 2.38231513 |
161 | lens fiber cell development (GO:0070307) | 2.37686269 |
162 | substantia nigra development (GO:0021762) | 2.37221810 |
163 | ER overload response (GO:0006983) | 2.37185239 |
164 | cranial suture morphogenesis (GO:0060363) | 2.36117446 |
165 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.33074175 |
166 | sphingoid metabolic process (GO:0046519) | 2.32505830 |
167 | negative regulation of endothelial cell proliferation (GO:0001937) | 2.32169764 |
168 | positive regulation of fatty acid oxidation (GO:0046321) | 2.30160601 |
169 | benzene-containing compound metabolic process (GO:0042537) | 2.30134129 |
170 | negative regulation of humoral immune response (GO:0002921) | 2.30059933 |
171 | estrogen biosynthetic process (GO:0006703) | 2.28542693 |
172 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.28042189 |
173 | steroid catabolic process (GO:0006706) | 2.28034765 |
174 | phospholipid translocation (GO:0045332) | 2.27652335 |
175 | lipid translocation (GO:0034204) | 2.27652335 |
176 | ADP metabolic process (GO:0046031) | 2.27599263 |
177 | one-carbon compound transport (GO:0019755) | 2.27010142 |
178 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.26622646 |
179 | plasma lipoprotein particle clearance (GO:0034381) | 2.26064435 |
180 | endocrine hormone secretion (GO:0060986) | 2.25231755 |
181 | triglyceride homeostasis (GO:0070328) | 2.24320397 |
182 | acylglycerol homeostasis (GO:0055090) | 2.24320397 |
183 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.23840060 |
184 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.22371527 |
185 | lung vasculature development (GO:0060426) | 2.21817913 |
186 | androgen metabolic process (GO:0008209) | 2.19926040 |
187 | regulation of triglyceride metabolic process (GO:0090207) | 2.18303894 |
188 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.17341929 |
189 | complement activation, alternative pathway (GO:0006957) | 2.14653824 |
190 | glycolipid catabolic process (GO:0019377) | 2.13600132 |
191 | ceramide catabolic process (GO:0046514) | 2.12379449 |
192 | amino sugar catabolic process (GO:0046348) | 2.12074317 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.77078874 |
2 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.61065625 |
3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.59927547 |
4 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.52689004 |
5 | VDR_22108803_ChIP-Seq_LS180_Human | 2.23105261 |
6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.22628030 |
7 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.22099863 |
8 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.08106347 |
9 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.05071344 |
10 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.03101454 |
11 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.99833854 |
12 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.94851211 |
13 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.93572401 |
14 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.90296807 |
15 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.89777415 |
16 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.87854379 |
17 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.85976318 |
18 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.85882874 |
19 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.85016908 |
20 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.84674036 |
21 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.82165347 |
22 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.80834611 |
23 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.76339523 |
24 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.75102313 |
25 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.74230851 |
26 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.71509952 |
27 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.70557401 |
28 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.70173705 |
29 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.68056472 |
30 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.66529464 |
31 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.63790834 |
32 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.61941178 |
33 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.59125020 |
34 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.58272603 |
35 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.54653311 |
36 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.54048678 |
37 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.53616187 |
38 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.52921287 |
39 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.50480270 |
40 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.50480270 |
41 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.49709363 |
42 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.47777639 |
43 | * STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.47698678 |
44 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.45702587 |
45 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.44874542 |
46 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.44759582 |
47 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.43832205 |
48 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.42957457 |
49 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.40876637 |
50 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.39123092 |
51 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.36716702 |
52 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.36452181 |
53 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.35653617 |
54 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.35254785 |
55 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.34174055 |
56 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.32454167 |
57 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.31352367 |
58 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.27633518 |
59 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.27633518 |
60 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.27395928 |
61 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.27063154 |
62 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.26400114 |
63 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.26021752 |
64 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.25855700 |
65 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.25818899 |
66 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.24667820 |
67 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.24508498 |
68 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.23559060 |
69 | * CDX2_22108803_ChIP-Seq_LS180_Human | 1.23006841 |
70 | AR_25329375_ChIP-Seq_VCAP_Human | 1.22633306 |
71 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.22477285 |
72 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.21955508 |
73 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.21934591 |
74 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.20954850 |
75 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.20435156 |
76 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.20088168 |
77 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.19840606 |
78 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.19408203 |
79 | CJUN_26792858_Chip-Seq_BT549_Human | 1.18925828 |
80 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.18297814 |
81 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.17169111 |
82 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.15909835 |
83 | * TP63_23658742_ChIP-Seq_EP156T_Human | 1.15307921 |
84 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.14593643 |
85 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.13770684 |
86 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.12759015 |
87 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.12584280 |
88 | RXR_22108803_ChIP-Seq_LS180_Human | 1.11979294 |
89 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.11617316 |
90 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.11442958 |
91 | P300_19829295_ChIP-Seq_ESCs_Human | 1.11290791 |
92 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.10536070 |
93 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.10444924 |
94 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.09839592 |
95 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.09628114 |
96 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.09127192 |
97 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.08941221 |
98 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.08639318 |
99 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.08446901 |
100 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.08327318 |
101 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.08155721 |
102 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.07970504 |
103 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.07713674 |
104 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.06905722 |
105 | STAT3_23295773_ChIP-Seq_U87_Human | 1.06702324 |
106 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.06468066 |
107 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.05469347 |
108 | * FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.04846385 |
109 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.04531632 |
110 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.04103919 |
111 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03945773 |
112 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.03463279 |
113 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.03357966 |
114 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.02738089 |
115 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.02212293 |
116 | TP53_16413492_ChIP-PET_HCT116_Human | 1.01775833 |
117 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.00719303 |
118 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.00007792 |
119 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.99484539 |
120 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.98959797 |
121 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.98094096 |
122 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.97806400 |
123 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.97406443 |
124 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.96161426 |
125 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.95426299 |
126 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.95293523 |
127 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.94069856 |
128 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.93826057 |
129 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.93571933 |
130 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.92692241 |
131 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.92466734 |
132 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.92453744 |
133 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.92212714 |
134 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.92122722 |
135 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.90592194 |
136 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.90226855 |
137 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.89847580 |
138 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.89800908 |
139 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.89800908 |
140 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.89661159 |
141 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.89399425 |
142 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.87379430 |
143 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.86890554 |
144 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.86571866 |
145 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.86316711 |
146 | * ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.85960222 |
147 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 0.85923613 |
148 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.85846925 |
149 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.85353630 |
150 | KDM2B_26808549_Chip-Seq_REH_Human | 0.84898437 |
151 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.84659818 |
152 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.84596104 |
153 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.83912407 |
154 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.83912407 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003011_delayed_dark_adaptation | 4.61669978 |
2 | MP0004782_abnormal_surfactant_physiolog | 4.36841472 |
3 | MP0000920_abnormal_myelination | 4.31613727 |
4 | MP0010678_abnormal_skin_adnexa | 3.81984221 |
5 | MP0003950_abnormal_plasma_membrane | 3.79915615 |
6 | MP0000383_abnormal_hair_follicle | 3.54780007 |
7 | MP0000566_synostosis | 3.47223468 |
8 | MP0003195_calcinosis | 3.44640596 |
9 | MP0002098_abnormal_vibrissa_morphology | 2.85811255 |
10 | MP0000579_abnormal_nail_morphology | 2.72302416 |
11 | MP0004885_abnormal_endolymph | 2.59918758 |
12 | MP0002796_impaired_skin_barrier | 2.51584770 |
13 | MP0001958_emphysema | 2.51016927 |
14 | MP0000647_abnormal_sebaceous_gland | 2.50098097 |
15 | MP0002139_abnormal_hepatobiliary_system | 2.41133071 |
16 | MP0000537_abnormal_urethra_morphology | 2.36491444 |
17 | MP0003690_abnormal_glial_cell | 2.33035732 |
18 | MP0001346_abnormal_lacrimal_gland | 2.32890614 |
19 | MP0000569_abnormal_digit_pigmentation | 2.31094995 |
20 | MP0001177_atelectasis | 2.30198696 |
21 | MP0003252_abnormal_bile_duct | 2.29646788 |
22 | MP0002295_abnormal_pulmonary_circulatio | 2.27927911 |
23 | MP0004043_abnormal_pH_regulation | 2.21721243 |
24 | MP0010234_abnormal_vibrissa_follicle | 2.19024326 |
25 | MP0000462_abnormal_digestive_system | 2.15412089 |
26 | MP0000762_abnormal_tongue_morphology | 2.10331257 |
27 | MP0004742_abnormal_vestibular_system | 2.06872612 |
28 | MP0008875_abnormal_xenobiotic_pharmacok | 2.04201484 |
29 | MP0002876_abnormal_thyroid_physiology | 2.03328499 |
30 | MP0003329_amyloid_beta_deposits | 2.01740666 |
31 | MP0005670_abnormal_white_adipose | 1.99733897 |
32 | MP0005409_darkened_coat_color | 1.97298672 |
33 | MP0006082_CNS_inflammation | 1.96510597 |
34 | MP0002133_abnormal_respiratory_system | 1.91641512 |
35 | MP0005388_respiratory_system_phenotype | 1.91641512 |
36 | MP0005167_abnormal_blood-brain_barrier | 1.87220007 |
37 | MP0005647_abnormal_sex_gland | 1.84852619 |
38 | MP0003453_abnormal_keratinocyte_physiol | 1.80097161 |
39 | MP0005451_abnormal_body_composition | 1.78528013 |
40 | MP0001501_abnormal_sleep_pattern | 1.71536348 |
41 | MP0005365_abnormal_bile_salt | 1.68354071 |
42 | MP0004381_abnormal_hair_follicle | 1.67776588 |
43 | MP0005083_abnormal_biliary_tract | 1.67405838 |
44 | MP0002148_abnormal_hypersensitivity_rea | 1.66404847 |
45 | MP0005164_abnormal_response_to | 1.61859464 |
46 | MP0010329_abnormal_lipoprotein_level | 1.55709984 |
47 | MP0004130_abnormal_muscle_cell | 1.55055384 |
48 | MP0010386_abnormal_urinary_bladder | 1.54527627 |
49 | MP0000343_altered_response_to | 1.54496117 |
50 | MP0003634_abnormal_glial_cell | 1.53518979 |
51 | MP0001851_eye_inflammation | 1.53241806 |
52 | MP0001905_abnormal_dopamine_level | 1.48778388 |
53 | MP0000377_abnormal_hair_follicle | 1.47639497 |
54 | MP0004019_abnormal_vitamin_homeostasis | 1.42948721 |
55 | MP0005408_hypopigmentation | 1.42735901 |
56 | MP0005275_abnormal_skin_tensile | 1.41994462 |
57 | MP0005501_abnormal_skin_physiology | 1.41766270 |
58 | MP0008004_abnormal_stomach_pH | 1.41499389 |
59 | MP0002254_reproductive_system_inflammat | 1.40334322 |
60 | MP0003828_pulmonary_edema | 1.39235215 |
61 | MP0005171_absent_coat_pigmentation | 1.39167054 |
62 | MP0001986_abnormal_taste_sensitivity | 1.37854583 |
63 | MP0004272_abnormal_basement_membrane | 1.37776190 |
64 | MP0001485_abnormal_pinna_reflex | 1.36724382 |
65 | MP0003186_abnormal_redox_activity | 1.35881509 |
66 | MP0002118_abnormal_lipid_homeostasis | 1.35667526 |
67 | MP0003937_abnormal_limbs/digits/tail_de | 1.33261849 |
68 | MP0008995_early_reproductive_senescence | 1.32514975 |
69 | MP0003279_aneurysm | 1.32383371 |
70 | MP0005595_abnormal_vascular_smooth | 1.31427509 |
71 | MP0009785_altered_susceptibility_to | 1.31026667 |
72 | MP0003632_abnormal_nervous_system | 1.28888362 |
73 | MP0005334_abnormal_fat_pad | 1.28863967 |
74 | MP0002419_abnormal_innate_immunity | 1.27553975 |
75 | MP0001756_abnormal_urination | 1.27396746 |
76 | MP0002998_abnormal_bone_remodeling | 1.24718425 |
77 | MP0000685_abnormal_immune_system | 1.23564323 |
78 | MP0005058_abnormal_lysosome_morphology | 1.22815219 |
79 | MP0009764_decreased_sensitivity_to | 1.21361287 |
80 | MP0003172_abnormal_lysosome_physiology | 1.18507456 |
81 | MP0004134_abnormal_chest_morphology | 1.17065681 |
82 | MP0000778_abnormal_nervous_system | 1.16846703 |
83 | MP0003075_altered_response_to | 1.16599322 |
84 | MP0004883_abnormal_blood_vessel | 1.15980963 |
85 | MP0000371_diluted_coat_color | 1.14798147 |
86 | MP0004185_abnormal_adipocyte_glucose | 1.13020663 |
87 | MP0001533_abnormal_skeleton_physiology | 1.12889737 |
88 | MP0005085_abnormal_gallbladder_physiolo | 1.09996054 |
89 | MP0000467_abnormal_esophagus_morphology | 1.09668900 |
90 | MP0010368_abnormal_lymphatic_system | 1.09261630 |
91 | MP0000465_gastrointestinal_hemorrhage | 1.08700906 |
92 | MP0009384_cardiac_valve_regurgitation | 1.07925076 |
93 | MP0010771_integument_phenotype | 1.07587868 |
94 | MP0003136_yellow_coat_color | 1.07288184 |
95 | MP0000613_abnormal_salivary_gland | 1.06948215 |
96 | MP0003724_increased_susceptibility_to | 1.06302689 |
97 | MP0001216_abnormal_epidermal_layer | 1.06108779 |
98 | MP0005410_abnormal_fertilization | 1.05989930 |
99 | MP0010030_abnormal_orbit_morphology | 1.02866405 |
100 | MP0002229_neurodegeneration | 1.00832232 |
101 | MP0004947_skin_inflammation | 0.99944396 |
102 | MP0001661_extended_life_span | 0.97717728 |
103 | MP0005666_abnormal_adipose_tissue | 0.97544249 |
104 | MP0002282_abnormal_trachea_morphology | 0.97516700 |
105 | MP0003303_peritoneal_inflammation | 0.96859171 |
106 | MP0005023_abnormal_wound_healing | 0.95947159 |
107 | MP0000534_abnormal_ureter_morphology | 0.95039011 |
108 | MP0005375_adipose_tissue_phenotype | 0.94837420 |
109 | MP0005025_abnormal_response_to | 0.94753034 |
110 | MP0006054_spinal_hemorrhage | 0.94534814 |
111 | MP0000249_abnormal_blood_vessel | 0.94520609 |
112 | MP0005551_abnormal_eye_electrophysiolog | 0.91814371 |
113 | MP0000604_amyloidosis | 0.89672069 |
114 | MP0004264_abnormal_extraembryonic_tissu | 0.88572148 |
115 | MP0000681_abnormal_thyroid_gland | 0.88241130 |
116 | MP0001879_abnormal_lymphatic_vessel | 0.87511432 |
117 | MP0003283_abnormal_digestive_organ | 0.87410425 |
118 | MP0001340_abnormal_eyelid_morphology | 0.87380861 |
119 | MP0002971_abnormal_brown_adipose | 0.86525305 |
120 | MP0002060_abnormal_skin_morphology | 0.86303664 |
121 | MP0001299_abnormal_eye_distance/ | 0.85527746 |
122 | MP0003436_decreased_susceptibility_to | 0.84381654 |
123 | MP0001845_abnormal_inflammatory_respons | 0.83830919 |
124 | MP0002233_abnormal_nose_morphology | 0.82599056 |
125 | MP0001853_heart_inflammation | 0.81983540 |
126 | MP0000427_abnormal_hair_cycle | 0.81346132 |
127 | MP0009643_abnormal_urine_homeostasis | 0.80935364 |
128 | MP0005166_decreased_susceptibility_to | 0.80734082 |
129 | MP0002933_joint_inflammation | 0.80502122 |
130 | MP0005253_abnormal_eye_physiology | 0.80369554 |
131 | MP0003646_muscle_fatigue | 0.80275790 |
132 | MP0005332_abnormal_amino_acid | 0.80101419 |
133 | MP0003191_abnormal_cellular_cholesterol | 0.79840248 |
134 | MP0002452_abnormal_antigen_presenting | 0.79521433 |
135 | MP0001849_ear_inflammation | 0.78959106 |
136 | MP0008469_abnormal_protein_level | 0.78531900 |
137 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.78474440 |
138 | MP0003938_abnormal_ear_development | 0.78154665 |
139 | MP0002009_preneoplasia | 0.76474106 |
140 | MP0005623_abnormal_meninges_morphology | 0.76445601 |
141 | MP0000230_abnormal_systemic_arterial | 0.76192476 |
142 | MP0009840_abnormal_foam_cell | 0.76056393 |
143 | MP0008438_abnormal_cutaneous_collagen | 0.75633914 |
144 | MP0002405_respiratory_system_inflammati | 0.75604043 |
145 | MP0002736_abnormal_nociception_after | 0.75530582 |
146 | MP0008260_abnormal_autophagy | 0.75349510 |
147 | MP0009115_abnormal_fat_cell | 0.75196785 |
148 | MP0001666_abnormal_nutrient_absorption | 0.75114372 |
149 | MP0002896_abnormal_bone_mineralization | 0.74645664 |
150 | MP0004270_analgesia | 0.74562865 |
151 | MP0001545_abnormal_hematopoietic_system | 0.73966207 |
152 | MP0005397_hematopoietic_system_phenotyp | 0.73966207 |
153 | MP0003806_abnormal_nucleotide_metabolis | 0.73865177 |
154 | MP0001963_abnormal_hearing_physiology | 0.72764057 |
155 | MP0002136_abnormal_kidney_physiology | 0.72274426 |
156 | MP0002138_abnormal_hepatobiliary_system | 0.70570115 |
157 | MP0009250_abnormal_appendicular_skeleto | 0.70434220 |
158 | MP0002277_abnormal_respiratory_mucosa | 0.70027871 |
159 | MP0003880_abnormal_central_pattern | 0.69962264 |
160 | MP0000003_abnormal_adipose_tissue | 0.68134785 |
161 | MP0001664_abnormal_digestion | 0.67473936 |
162 | MP0001790_abnormal_immune_system | 0.66433267 |
163 | MP0005387_immune_system_phenotype | 0.66433267 |
164 | MP0003631_nervous_system_phenotype | 0.66408413 |
165 | MP0002132_abnormal_respiratory_system | 0.66158981 |
166 | MP0001486_abnormal_startle_reflex | 0.65792981 |
167 | MP0005195_abnormal_posterior_eye | 0.65066682 |
168 | MP0001529_abnormal_vocalization | 0.64956078 |
169 | MP0000470_abnormal_stomach_morphology | 0.61441209 |
170 | MP0001943_abnormal_respiration | 0.60639077 |
171 | MP0002272_abnormal_nervous_system | 0.59760010 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Neurofibrillary tangles (HP:0002185) | 6.14637102 |
2 | Genetic anticipation (HP:0003743) | 5.42085187 |
3 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 5.38656947 |
4 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 5.38656947 |
5 | Abnormality of glycolipid metabolism (HP:0010969) | 5.35048479 |
6 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.35048479 |
7 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.35048479 |
8 | Prostate neoplasm (HP:0100787) | 5.00208584 |
9 | Action tremor (HP:0002345) | 4.89225714 |
10 | Interstitial pulmonary disease (HP:0006530) | 4.69784432 |
11 | Parakeratosis (HP:0001036) | 4.67301620 |
12 | Cerebral inclusion bodies (HP:0100314) | 4.41012724 |
13 | Dysmetric saccades (HP:0000641) | 4.01304463 |
14 | Systemic lupus erythematosus (HP:0002725) | 3.97401461 |
15 | Vacuolated lymphocytes (HP:0001922) | 3.77896067 |
16 | Progressive cerebellar ataxia (HP:0002073) | 3.67277638 |
17 | Sensory axonal neuropathy (HP:0003390) | 3.52217011 |
18 | Abnormality of the hepatic vasculature (HP:0006707) | 3.50030794 |
19 | Abnormality of the corticospinal tract (HP:0002492) | 3.46297550 |
20 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.44344547 |
21 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 3.43277033 |
22 | Dysostosis multiplex (HP:0000943) | 3.43182698 |
23 | Abnormality of the middle phalanges of the toes (HP:0010183) | 3.38505280 |
24 | Congenital ichthyosiform erythroderma (HP:0007431) | 3.34998022 |
25 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.34931639 |
26 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.34931639 |
27 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.34931639 |
28 | Renal salt wasting (HP:0000127) | 3.29849375 |
29 | Peripheral hypomyelination (HP:0007182) | 3.29305824 |
30 | Mucopolysacchariduria (HP:0008155) | 3.28118532 |
31 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.28118532 |
32 | Complement deficiency (HP:0004431) | 3.21312081 |
33 | Loss of speech (HP:0002371) | 3.16775215 |
34 | Increased cerebral lipofuscin (HP:0011813) | 3.14330800 |
35 | Stomach cancer (HP:0012126) | 3.10568892 |
36 | Hypokalemic alkalosis (HP:0001949) | 3.08295712 |
37 | Synostosis involving the elbow (HP:0003938) | 3.05223906 |
38 | Humeroradial synostosis (HP:0003041) | 3.05223906 |
39 | Onion bulb formation (HP:0003383) | 3.03155523 |
40 | Aplasia involving bones of the upper limbs (HP:0009823) | 3.02962998 |
41 | Aplasia of the phalanges of the hand (HP:0009802) | 3.02962998 |
42 | Aplasia involving bones of the extremities (HP:0009825) | 3.02962998 |
43 | Alacrima (HP:0000522) | 3.00072881 |
44 | Supranuclear gaze palsy (HP:0000605) | 2.98487079 |
45 | Ulnar bowing (HP:0003031) | 2.94911970 |
46 | Myocardial infarction (HP:0001658) | 2.90830079 |
47 | Stenosis of the external auditory canal (HP:0000402) | 2.90818962 |
48 | Premature skin wrinkling (HP:0100678) | 2.89344085 |
49 | Thickened helices (HP:0000391) | 2.88684226 |
50 | Glomerulonephritis (HP:0000099) | 2.85129383 |
51 | Intention tremor (HP:0002080) | 2.84853619 |
52 | Gaze-evoked nystagmus (HP:0000640) | 2.83682432 |
53 | Stridor (HP:0010307) | 2.80532005 |
54 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.80511005 |
55 | Hyperactive renin-angiotensin system (HP:0000841) | 2.79898847 |
56 | Hyperventilation (HP:0002883) | 2.79121407 |
57 | Keratoconus (HP:0000563) | 2.77267472 |
58 | Increased corneal curvature (HP:0100692) | 2.77267472 |
59 | Onycholysis (HP:0001806) | 2.76637759 |
60 | Tubulointerstitial fibrosis (HP:0005576) | 2.66829074 |
61 | Anteriorly placed anus (HP:0001545) | 2.64217196 |
62 | Morphological abnormality of the inner ear (HP:0011390) | 2.63905809 |
63 | Pendular nystagmus (HP:0012043) | 2.62528025 |
64 | Barrel-shaped chest (HP:0001552) | 2.60284930 |
65 | Abnormality of the 2nd finger (HP:0004100) | 2.60064285 |
66 | Tubular atrophy (HP:0000092) | 2.55647360 |
67 | Hematochezia (HP:0002573) | 2.53898950 |
68 | Cupped ear (HP:0000378) | 2.53844679 |
69 | Increased circulating renin level (HP:0000848) | 2.53589292 |
70 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.53226575 |
71 | Hypomagnesemia (HP:0002917) | 2.53089801 |
72 | Metabolic alkalosis (HP:0200114) | 2.51887880 |
73 | Coronal craniosynostosis (HP:0004440) | 2.49790755 |
74 | Split foot (HP:0001839) | 2.49450493 |
75 | Postural tremor (HP:0002174) | 2.44069012 |
76 | Abnormality of chloride homeostasis (HP:0011422) | 2.43708938 |
77 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.42709265 |
78 | Abnormality of the prostate (HP:0008775) | 2.42688775 |
79 | Megalencephaly (HP:0001355) | 2.41476119 |
80 | Hypotrichosis (HP:0001006) | 2.41474029 |
81 | Abnormal drinking behavior (HP:0030082) | 2.39714633 |
82 | Polydipsia (HP:0001959) | 2.39714633 |
83 | Abnormality of complement system (HP:0005339) | 2.39367586 |
84 | Congenital sensorineural hearing impairment (HP:0008527) | 2.38120497 |
85 | Autoamputation (HP:0001218) | 2.37775124 |
86 | Respiratory distress (HP:0002098) | 2.34191813 |
87 | Cerebral hypomyelination (HP:0006808) | 2.32845833 |
88 | Abnormal auditory evoked potentials (HP:0006958) | 2.32734642 |
89 | Fragile nails (HP:0001808) | 2.32635374 |
90 | Abnormality of macrophages (HP:0004311) | 2.31771997 |
91 | Partial duplication of thumb phalanx (HP:0009944) | 2.31371332 |
92 | Bifid scrotum (HP:0000048) | 2.29791346 |
93 | Steatorrhea (HP:0002570) | 2.29787463 |
94 | Esophageal atresia (HP:0002032) | 2.29695681 |
95 | Hyperaldosteronism (HP:0000859) | 2.28828307 |
96 | Ovoid vertebral bodies (HP:0003300) | 2.28368249 |
97 | Cerebral hemorrhage (HP:0001342) | 2.26833075 |
98 | Absence seizures (HP:0002121) | 2.26533691 |
99 | Nephritis (HP:0000123) | 2.26247508 |
100 | Decreased circulating renin level (HP:0003351) | 2.25036573 |
101 | Abnormality of cochlea (HP:0000375) | 2.23900241 |
102 | Hyperkalemia (HP:0002153) | 2.22106855 |
103 | Autoimmune thrombocytopenia (HP:0001973) | 2.18972396 |
104 | Abnormality of renin-angiotensin system (HP:0000847) | 2.18947346 |
105 | Woolly hair (HP:0002224) | 2.18818503 |
106 | Bone cyst (HP:0012062) | 2.18242032 |
107 | Erythroderma (HP:0001019) | 2.17873322 |
108 | Decreased lacrimation (HP:0000633) | 2.14443706 |
109 | Follicular hyperkeratosis (HP:0007502) | 2.13620419 |
110 | Portal hypertension (HP:0001409) | 2.11452395 |
111 | Abnormality of incisor morphology (HP:0011063) | 2.09663131 |
112 | Severe visual impairment (HP:0001141) | 2.08102525 |
113 | Hepatosplenomegaly (HP:0001433) | 2.06926558 |
114 | Hypoplasia of the odontoid process (HP:0003311) | 2.06791465 |
115 | Nasolacrimal duct obstruction (HP:0000579) | 2.06112726 |
116 | Slow saccadic eye movements (HP:0000514) | 2.03735512 |
117 | Xanthomatosis (HP:0000991) | 2.02980602 |
118 | Spondylolisthesis (HP:0003302) | 2.02950340 |
119 | Hyporeflexia of lower limbs (HP:0002600) | 2.01943638 |
120 | Mixed hearing impairment (HP:0000410) | 2.01562077 |
121 | Insidious onset (HP:0003587) | 2.00065576 |
122 | Termporal pattern (HP:0011008) | 2.00065576 |
123 | Glomerulosclerosis (HP:0000096) | 1.99195389 |
124 | Fair hair (HP:0002286) | 1.98824144 |
125 | Abnormal umbilical cord blood vessels (HP:0011403) | 1.97899596 |
126 | Single umbilical artery (HP:0001195) | 1.97899596 |
127 | Abnormality of the fetal cardiovascular system (HP:0010948) | 1.97899596 |
128 | Metaphyseal irregularity (HP:0003025) | 1.95523634 |
129 | Corneal erosion (HP:0200020) | 1.95487076 |
130 | Mutism (HP:0002300) | 1.95432381 |
131 | Short hallux (HP:0010109) | 1.95365304 |
132 | Partial duplication of the phalanx of hand (HP:0009999) | 1.94682691 |
133 | Tachypnea (HP:0002789) | 1.93901748 |
134 | Polyuria (HP:0000103) | 1.93824379 |
135 | Prolonged neonatal jaundice (HP:0006579) | 1.93803527 |
136 | Hypoplastic labia majora (HP:0000059) | 1.92807336 |
137 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.92298977 |
138 | Muscle fiber splitting (HP:0003555) | 1.91367606 |
139 | Hypoplasia of the iris (HP:0007676) | 1.89897158 |
140 | Abolished electroretinogram (ERG) (HP:0000550) | 1.87968115 |
141 | Macular degeneration (HP:0000608) | 1.87418555 |
142 | Abnormality of the periventricular white matter (HP:0002518) | 1.87253146 |
143 | Neoplasm of head and neck (HP:0012288) | 1.86857105 |
144 | Esophageal neoplasm (HP:0100751) | 1.86857105 |
145 | Tubulointerstitial abnormality (HP:0001969) | 1.86797978 |
146 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 1.86615658 |
147 | Thick nail (HP:0001805) | 1.85926212 |
148 | Bell-shaped thorax (HP:0001591) | 1.85427327 |
149 | Abnormality of proline metabolism (HP:0010907) | 1.84840190 |
150 | Hydroxyprolinuria (HP:0003080) | 1.84840190 |
151 | Clumsiness (HP:0002312) | 1.84821811 |
152 | Conical tooth (HP:0000698) | 1.84383410 |
153 | Seborrheic dermatitis (HP:0001051) | 1.84171292 |
154 | Retinal atrophy (HP:0001105) | 1.84138171 |
155 | Abnormality of macular pigmentation (HP:0008002) | 1.83968733 |
156 | Chronic otitis media (HP:0000389) | 1.82550897 |
157 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.82231503 |
158 | Postural instability (HP:0002172) | 1.82108073 |
159 | Adrenal hypoplasia (HP:0000835) | 1.80298793 |
160 | Small epiphyses (HP:0010585) | 1.79769888 |
161 | Abnormality of magnesium homeostasis (HP:0004921) | 1.79602661 |
162 | Macroglossia (HP:0000158) | 1.79434459 |
163 | Spastic gait (HP:0002064) | 1.79429563 |
164 | Pancreatic cysts (HP:0001737) | 1.78554060 |
165 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.78186252 |
166 | Broad metatarsal (HP:0001783) | 1.78004772 |
167 | Disproportionate short-trunk short stature (HP:0003521) | 1.77298424 |
168 | Congenital stationary night blindness (HP:0007642) | 1.75380291 |
169 | Increased CSF protein (HP:0002922) | 1.74836939 |
170 | Abnormality of the renal cortex (HP:0011035) | 1.73839049 |
171 | Retinal dysplasia (HP:0007973) | 1.73744823 |
172 | Abnormality of molar (HP:0011077) | 1.73603970 |
173 | Abnormality of molar morphology (HP:0011070) | 1.73603970 |
174 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 1.73195299 |
175 | Dialeptic seizures (HP:0011146) | 1.72804758 |
176 | Mitral stenosis (HP:0001718) | 1.72487695 |
177 | Axonal loss (HP:0003447) | 1.71738277 |
178 | Xerostomia (HP:0000217) | 1.71401018 |
179 | Abnormality of the salivary glands (HP:0010286) | 1.70935171 |
180 | Congenital, generalized hypertrichosis (HP:0004540) | 1.70796906 |
181 | Abnormality of renal excretion (HP:0011036) | 1.70231809 |
182 | Abnormal urine output (HP:0012590) | 1.68895478 |
183 | Thyroid-stimulating hormone excess (HP:0002925) | 1.68543210 |
184 | Generalized hypopigmentation of hair (HP:0011358) | 1.68325448 |
185 | Amyloidosis (HP:0011034) | 1.67193859 |
186 | Poor head control (HP:0002421) | 1.64494614 |
187 | Joint stiffness (HP:0001387) | 1.64212244 |
188 | Chorioretinal atrophy (HP:0000533) | 1.63037221 |
189 | Widely spaced teeth (HP:0000687) | 1.60487835 |
190 | Metaphyseal dysplasia (HP:0100255) | 1.60291838 |
191 | Pulmonary artery stenosis (HP:0004415) | 1.60001125 |
Rank | Gene Set | Z-score |
---|---|---|
1 | STK39 | 6.41295319 |
2 | EPHB1 | 4.39767814 |
3 | OXSR1 | 4.15237335 |
4 | MST4 | 4.02306838 |
5 | FGFR2 | 3.79520686 |
6 | WNK4 | 3.08202330 |
7 | ACVR1B | 3.02862133 |
8 | ADRBK2 | 2.83434958 |
9 | MAP4K2 | 2.65940905 |
10 | PBK | 2.61735306 |
11 | BCR | 2.38252104 |
12 | MAPKAPK5 | 2.27339344 |
13 | PKN1 | 2.26827490 |
14 | TAOK3 | 2.15577409 |
15 | MET | 2.12505014 |
16 | PDK2 | 2.11571936 |
17 | WNK1 | 2.05868906 |
18 | MAPK15 | 1.63132800 |
19 | CLK1 | 1.60931430 |
20 | LIMK1 | 1.60702255 |
21 | CSNK1A1L | 1.49532070 |
22 | PINK1 | 1.44156502 |
23 | CAMKK2 | 1.40817383 |
24 | PRPF4B | 1.35951128 |
25 | SGK223 | 1.33956810 |
26 | SGK494 | 1.33956810 |
27 | EPHA2 | 1.33795924 |
28 | ROCK2 | 1.32328307 |
29 | GRK7 | 1.29876194 |
30 | NEK6 | 1.24778137 |
31 | MAPKAPK3 | 1.24701257 |
32 | CSNK1G3 | 1.23571898 |
33 | IKBKB | 1.21312075 |
34 | ABL2 | 1.20876957 |
35 | TESK2 | 1.19732546 |
36 | ADRBK1 | 1.19219889 |
37 | CAMK2B | 1.18671332 |
38 | TRPM7 | 1.18431849 |
39 | STK10 | 1.14357736 |
40 | JAK1 | 1.14244714 |
41 | CSNK1G1 | 1.10903699 |
42 | EPHA3 | 1.10502753 |
43 | PRKD1 | 1.09381867 |
44 | PRKAA2 | 1.05452418 |
45 | MAP2K2 | 1.05288480 |
46 | TGFBR1 | 1.03817368 |
47 | DAPK2 | 1.02841596 |
48 | PRKCQ | 1.02493151 |
49 | TXK | 1.01957766 |
50 | STK38L | 1.01577245 |
51 | KIT | 1.00610557 |
52 | TYK2 | 0.99599866 |
53 | NTRK1 | 0.96032566 |
54 | NEK9 | 0.94619636 |
55 | PAK3 | 0.93365318 |
56 | MAP3K2 | 0.93275200 |
57 | PDGFRB | 0.92839641 |
58 | MUSK | 0.91988318 |
59 | IRAK3 | 0.87141654 |
60 | CDK19 | 0.86029868 |
61 | LRRK2 | 0.85567657 |
62 | FGR | 0.83961143 |
63 | UHMK1 | 0.83735252 |
64 | GSK3A | 0.81808795 |
65 | MARK2 | 0.81669312 |
66 | CSNK1G2 | 0.81402152 |
67 | MAP3K13 | 0.81274706 |
68 | WNK3 | 0.80018323 |
69 | TYRO3 | 0.79800665 |
70 | CAMK2D | 0.78867272 |
71 | HIPK2 | 0.75882765 |
72 | TIE1 | 0.75430395 |
73 | MYLK | 0.74981363 |
74 | PDK1 | 0.74914307 |
75 | CHUK | 0.73655635 |
76 | ITK | 0.73637383 |
77 | JAK2 | 0.73444037 |
78 | RPS6KA5 | 0.72639572 |
79 | ICK | 0.72380144 |
80 | LATS1 | 0.70271892 |
81 | FER | 0.69742025 |
82 | LATS2 | 0.68388049 |
83 | DDR2 | 0.66531318 |
84 | STK38 | 0.66061608 |
85 | ERN1 | 0.65835327 |
86 | PRKCE | 0.63942274 |
87 | GRK1 | 0.62759255 |
88 | BMPR1B | 0.62716948 |
89 | NLK | 0.60151621 |
90 | JAK3 | 0.59752256 |
91 | CAMK2G | 0.59741809 |
92 | STK4 | 0.58904502 |
93 | STK11 | 0.58427355 |
94 | TBK1 | 0.54888418 |
95 | FGFR3 | 0.52859813 |
96 | MAP3K14 | 0.52605952 |
97 | DYRK2 | 0.51434941 |
98 | CDC42BPA | 0.51105269 |
99 | MAPK12 | 0.50037757 |
100 | MATK | 0.49172950 |
101 | PDPK1 | 0.49006506 |
102 | PTK2B | 0.48742813 |
103 | CSNK1D | 0.48383477 |
104 | IGF1R | 0.48013096 |
105 | MELK | 0.47858250 |
106 | FYN | 0.47529315 |
107 | CAMK1D | 0.47378409 |
108 | STK24 | 0.45146175 |
109 | CSK | 0.44334539 |
110 | NUAK1 | 0.43358397 |
111 | MAP2K1 | 0.42729640 |
112 | PRKCH | 0.40495198 |
113 | IKBKE | 0.40193771 |
114 | MAPK7 | 0.39866975 |
115 | MKNK2 | 0.39629430 |
116 | MAP2K6 | 0.39606696 |
117 | MAPK4 | 0.39220953 |
118 | FRK | 0.38394081 |
119 | YES1 | 0.37965490 |
120 | CSF1R | 0.37902102 |
121 | MAP3K3 | 0.37898383 |
122 | INSRR | 0.37829222 |
123 | MST1R | 0.37200173 |
124 | INSR | 0.37178385 |
125 | MAPKAPK2 | 0.34919863 |
126 | FGFR1 | 0.34760180 |
127 | BCKDK | 0.33371909 |
128 | ZAP70 | 0.33046723 |
129 | EPHB2 | 0.32473498 |
130 | CSNK1A1 | 0.32334555 |
131 | SGK2 | 0.32318141 |
132 | DMPK | 0.31844696 |
133 | BRSK2 | 0.31640620 |
134 | RPS6KA2 | 0.31394192 |
135 | PTK6 | 0.31153854 |
136 | CAMK2A | 0.30881816 |
137 | STK3 | 0.30650387 |
138 | ABL1 | 0.30490624 |
139 | TGFBR2 | 0.29914915 |
140 | TNK2 | 0.29658535 |
141 | PRKG1 | 0.29522100 |
142 | MAP3K7 | 0.29408657 |
143 | CASK | 0.28793045 |
144 | PTK2 | 0.28463147 |
145 | ILK | 0.27939149 |
146 | AKT3 | 0.27644735 |
147 | PNCK | 0.27055600 |
148 | BLK | 0.26469480 |
149 | ROCK1 | 0.24553476 |
150 | FGFR4 | 0.24504702 |
151 | IRAK1 | 0.22569897 |
152 | PIK3CA | 0.22432144 |
153 | EGFR | 0.21914350 |
154 | PRKD2 | 0.21164684 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 4.38335063 |
2 | Fatty acid elongation_Homo sapiens_hsa00062 | 4.28323780 |
3 | Steroid biosynthesis_Homo sapiens_hsa00100 | 4.22138619 |
4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.01922138 |
5 | Ether lipid metabolism_Homo sapiens_hsa00565 | 3.15607113 |
6 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.97353508 |
7 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.55822495 |
8 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.45550309 |
9 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.38777694 |
10 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.26509203 |
11 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 2.20569185 |
12 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.19846704 |
13 | Histidine metabolism_Homo sapiens_hsa00340 | 2.18160553 |
14 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.14503409 |
15 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.02655908 |
16 | Other glycan degradation_Homo sapiens_hsa00511 | 2.02512861 |
17 | Protein export_Homo sapiens_hsa03060 | 1.97082300 |
18 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.89710438 |
19 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.83073715 |
20 | Mineral absorption_Homo sapiens_hsa04978 | 1.79445185 |
21 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.79410833 |
22 | Tight junction_Homo sapiens_hsa04530 | 1.77827012 |
23 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.76244536 |
24 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.73764058 |
25 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.71584385 |
26 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.70840710 |
27 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.70561546 |
28 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.62396626 |
29 | Axon guidance_Homo sapiens_hsa04360 | 1.55878243 |
30 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.49437968 |
31 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.35662959 |
32 | Asthma_Homo sapiens_hsa05310 | 1.34904699 |
33 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.34574206 |
34 | Pertussis_Homo sapiens_hsa05133 | 1.29125402 |
35 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.28709719 |
36 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.26916388 |
37 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.26305354 |
38 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.25384662 |
39 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.25191570 |
40 | Allograft rejection_Homo sapiens_hsa05330 | 1.21414618 |
41 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.18970072 |
42 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.13883545 |
43 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.13724227 |
44 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.08890978 |
45 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.08100026 |
46 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.07550400 |
47 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.06983410 |
48 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.06887779 |
49 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.03791788 |
50 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.02022568 |
51 | Lysosome_Homo sapiens_hsa04142 | 1.01170961 |
52 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.99132890 |
53 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.98814407 |
54 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.95688486 |
55 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.93268896 |
56 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.92954997 |
57 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.89783309 |
58 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.87746651 |
59 | Circadian rhythm_Homo sapiens_hsa04710 | 0.85752130 |
60 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.85240415 |
61 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.85177901 |
62 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.84154129 |
63 | Endocytosis_Homo sapiens_hsa04144 | 0.80652846 |
64 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.80441855 |
65 | Prostate cancer_Homo sapiens_hsa05215 | 0.78855044 |
66 | Leishmaniasis_Homo sapiens_hsa05140 | 0.77912551 |
67 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.76516187 |
68 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.74712855 |
69 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.73428333 |
70 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.73194075 |
71 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.72620959 |
72 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.72041712 |
73 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.71967364 |
74 | Tuberculosis_Homo sapiens_hsa05152 | 0.70793467 |
75 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.69671032 |
76 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.69601749 |
77 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.69136463 |
78 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.68915186 |
79 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.68565793 |
80 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.68007687 |
81 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.67504283 |
82 | Adherens junction_Homo sapiens_hsa04520 | 0.67139901 |
83 | ABC transporters_Homo sapiens_hsa02010 | 0.67008784 |
84 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.66733199 |
85 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.66568760 |
86 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.66433051 |
87 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.66122723 |
88 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.65314347 |
89 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.62339643 |
90 | Phagosome_Homo sapiens_hsa04145 | 0.61943205 |
91 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.61702308 |
92 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.61368782 |
93 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.61305604 |
94 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.61117914 |
95 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.60946708 |
96 | Bile secretion_Homo sapiens_hsa04976 | 0.60271876 |
97 | Malaria_Homo sapiens_hsa05144 | 0.59588206 |
98 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.59156978 |
99 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.59154894 |
100 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.58547559 |
101 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.54958745 |
102 | Hepatitis C_Homo sapiens_hsa05160 | 0.54623286 |
103 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.53818680 |
104 | Focal adhesion_Homo sapiens_hsa04510 | 0.53457772 |
105 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.53327403 |
106 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.52988953 |
107 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.50802195 |
108 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.50622159 |
109 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.50380402 |
110 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.49230536 |
111 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.47632842 |
112 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.45964123 |
113 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.45941270 |
114 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.45857065 |
115 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.45048825 |
116 | Influenza A_Homo sapiens_hsa05164 | 0.43640596 |
117 | Long-term depression_Homo sapiens_hsa04730 | 0.43137055 |
118 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.42883288 |
119 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.42491084 |
120 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.42166329 |
121 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.41580453 |
122 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.41139885 |
123 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.40636450 |
124 | Retinol metabolism_Homo sapiens_hsa00830 | 0.40589601 |
125 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.40382402 |
126 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.39986479 |
127 | Legionellosis_Homo sapiens_hsa05134 | 0.39295435 |
128 | Insulin resistance_Homo sapiens_hsa04931 | 0.39254879 |
129 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.39160329 |
130 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.38827431 |
131 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.38809948 |
132 | Pathways in cancer_Homo sapiens_hsa05200 | 0.38463704 |
133 | Phototransduction_Homo sapiens_hsa04744 | 0.38266969 |
134 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.38016993 |
135 | Cocaine addiction_Homo sapiens_hsa05030 | 0.36706047 |
136 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.35839993 |
137 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.35511344 |
138 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.34823246 |
139 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.33961565 |
140 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.33827813 |
141 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.33503312 |
142 | Platelet activation_Homo sapiens_hsa04611 | 0.33438216 |
143 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.32913829 |
144 | Salivary secretion_Homo sapiens_hsa04970 | 0.32848292 |
145 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.32444664 |
146 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.31774795 |
147 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.31624193 |
148 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.31609786 |
149 | Amoebiasis_Homo sapiens_hsa05146 | 0.30690095 |
150 | Peroxisome_Homo sapiens_hsa04146 | 0.30497203 |
151 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.29670964 |
152 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.29373428 |
153 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.29115860 |